217
Participants
Start Date
August 30, 2013
Primary Completion Date
October 31, 2027
Study Completion Date
October 31, 2027
Molecular imaging
On the day of FES-injection\&scan or the day after FES-injection, 89Zr-trastuzumab (\~37 MBq) will be injected. The HER2-PET will be performed 4 days after tracerinjection.
Molecular imaging
All patients receive 18F-FES (\~200MBq) injection followed by a FES-PET.
VU University Medical Center, Amsterdam
University Medical Center St. Radboud, Nijmegen
University Medical Center, Groningen
Amsterdam UMC, location VUmc
OTHER
University Medical Center Nijmegen
OTHER
University Medical Center Groningen
OTHER